hotspot -WSS

hotspot

author：focus 2025-09-07 14:07:26 - browse：3

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Elevance, private equity launch primary care company

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

A $475,000 price tag for a new cancer drug: crazy or meh?

After gene therapy, two congenitally deaf children hear for the first time

What nurses really want: sufficient staffing for patient care

How to improve immunocompromised access to mAb treatments

Even great ERs can’t make up for American health disparities

leisure time

hotspot

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

SAMSHA loosens regulations on methadone treatment centers

Hollywood unions extend contract negotiations for actors

Apple Watch's A

New air purifier tech could be key to improving indoor air quality

Commercial surrogacy can be ethical, despite pope’s claims

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cybersecurity threat forces Lurie Children's to take systems offline

Continuity nursing helped my family in our darkest PICU moments

How to improve immunocompromised access to mAb treatments

hotspot

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Commercial surrogacy can be ethical, despite pope’s claims

CDC wastewater surveillance dashboard to track bird flu hotspots

Medicare drug price negotiation’s day in court

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

entertainment

leisure time

focus